United Therapeutics

United Therapeutics was founded by the parents of a child diagnosed with pulmonary arterial hypertension (PAH). Faced with a lack of information, support, and therapy options, they set out on a very personal quest to help change the future for people impacted by PAH. Since United Therapeutics was founded in 1996, thousands of patients around the world have benefited from our commitment to the PAH community.

Our mission

United Therapeutics is constantly working to develop innovative treatment to address the medical needs of patients with chronic and life-threatening conditions.

Considering Orenitram Patient
TYVASO Take a look at what Tyvaso can do